Diagnosis and augmentation therapy for alpha-1 antitrypsin deficiency: current knowledge and future potential.

Drugs Context · 2023 · PMC10379007 · PMID 37521109

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

41 After 2 years of AAT treatment, a statistically significant reduction in the annual rate of CT lung density loss and the total lung capacity (TLC) was observed, whilst functional residual capacity alone or TLC plus functional residual capacity did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.